Open access · US-GOV via ClinicalTrials.gov Clinical trial

Defining Mechanisms for Cardiac Allograft Dysfunction to Improve Allograft Longevity and Survival in Heart-Transplant Patients

Authors not listed

Paul Kim · 2019

Mitochondrial dysfunction Human Randomized controlled trial

Abstract

The investigators will evaluate for early evidence of cardiac allograft dysfunction by cardiac MRI and single cell sequencing to determine underlying molecular and macroscopic causes.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-18 MST

Cite this

APA

Anonymous. (2019). Defining Mechanisms for Cardiac Allograft Dysfunction to Improve Allograft Longevity and Survival in Heart-Transplant Patients. <em>Paul Kim</em>. https://clinicaltrials.gov/study/NCT03102125

Vancouver

Anonymous. Defining Mechanisms for Cardiac Allograft Dysfunction to Improve Allograft Longevity and Survival in Heart-Transplant Patients. Paul Kim. 2019.

BibTeX

@misc{anon2019Defini, title = {Defining Mechanisms for Cardiac Allograft Dysfunction to Improve Allograft Longevity and Survival in Heart-Transplant Patients}, author = {Anonymous}, journal = {Paul Kim}, year = {2019}, }